Selected research
Industry Research
Radiation Injury Drugs Industry Research Report 2026
Market perspective
The global Radiation Injury Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Radiation Injury Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Radiation Injury Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Radiation Injury Drugs include Windtree Therapeutics Inc, Tonix Pharmaceuticals Holding Corp, Synedgen Inc, PharmaIN Corp and FirstString Research Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Radiation Injury Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Radiation Injury Drugs Market by Company
Windtree Therapeutics Inc
Tonix Pharmaceuticals Holding Corp
Synedgen Inc
PharmaIN Corp
FirstString Research Inc
Radiation Injury Drugs Segment by Type
DG-3
Des-Asp Angiotensin 1
C-2E5
C-2E2
BMX-001
Aerosurf
Others
Radiation Injury Drugs Segment by Application
Hospital
Clinic
ASCs
Others
Radiation Injury Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiation Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Injury Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Radiation Injury Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Radiation Injury Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Radiation Injury Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DG-3
- Des-Asp Angiotensin 1
- C-2E5
- C-2E2
- BMX-001
- Aerosurf
- Others
Applications
- Hospital
- Clinic
- ASCs
- Others
Companies covered
- Windtree Therapeutics Inc
- Tonix Pharmaceuticals Holding Corp
- Synedgen Inc
- PharmaIN Corp
- FirstString Research Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Radiation Injury Drugs Market Size (2021-2032)
- 2.2.2 Global Radiation Injury Drugs Sales (2021-2032)
- 2.2.3 Global Radiation Injury Drugs Market Average Price (2021-2032)
- 2.3 Radiation Injury Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DG-3
- 2.3.3 Des-Asp Angiotensin 1
- 2.3.4 C-2E5
- 2.3.5 C-2E2
- 2.3.6 BMX-001
- 2.3.7 Aerosurf
- 2.3.8 Others
- 2.4 Radiation Injury Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 ASCs
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Radiation Injury Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Radiation Injury Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Radiation Injury Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Radiation Injury Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Radiation Injury Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Radiation Injury Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Radiation Injury Drugs, Product Type & Application
- 3.8 Global Manufacturers of Radiation Injury Drugs, Established Date
- 3.9 Global Radiation Injury Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Windtree Therapeutics Inc
- 4.1.1 Windtree Therapeutics Inc Company Information
- 4.1.2 Windtree Therapeutics Inc Business Overview
- 4.1.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio
- 4.1.5 Windtree Therapeutics Inc Recent Developments
- 4.2 Tonix Pharmaceuticals Holding Corp
- 4.2.1 Tonix Pharmaceuticals Holding Corp Company Information
- 4.2.2 Tonix Pharmaceuticals Holding Corp Business Overview
- 4.2.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio
- 4.2.5 Tonix Pharmaceuticals Holding Corp Recent Developments
- 4.3 Synedgen Inc
- 4.3.1 Synedgen Inc Company Information
- 4.3.2 Synedgen Inc Business Overview
- 4.3.3 Synedgen Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Synedgen Inc Radiation Injury Drugs Product Portfolio
- 4.3.5 Synedgen Inc Recent Developments
- 4.4 PharmaIN Corp
- 4.4.1 PharmaIN Corp Company Information
- 4.4.2 PharmaIN Corp Business Overview
- 4.4.3 PharmaIN Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PharmaIN Corp Radiation Injury Drugs Product Portfolio
- 4.4.5 PharmaIN Corp Recent Developments
- 4.5 FirstString Research Inc
- 4.5.1 FirstString Research Inc Company Information
- 4.5.2 FirstString Research Inc Business Overview
- 4.5.3 FirstString Research Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 FirstString Research Inc Radiation Injury Drugs Product Portfolio
- 4.5.5 FirstString Research Inc Recent Developments
5 Global Radiation Injury Drugs Market Scenario by Region
- 5.1 Global Radiation Injury Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Radiation Injury Drugs Sales by Region: 2021-2032
- 5.2.1 Global Radiation Injury Drugs Sales by Region: 2021-2026
- 5.2.2 Global Radiation Injury Drugs Sales by Region: 2027-2032
- 5.3 Global Radiation Injury Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Radiation Injury Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Radiation Injury Drugs Revenue by Region: 2027-2032
- 5.4 North America Radiation Injury Drugs Market Facts & Figures by Country
- 5.4.1 North America Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Radiation Injury Drugs Sales by Country (2021-2032)
- 5.4.3 North America Radiation Injury Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Radiation Injury Drugs Market Facts & Figures by Country
- 5.5.1 Europe Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Radiation Injury Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Radiation Injury Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Radiation Injury Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Radiation Injury Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Radiation Injury Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Radiation Injury Drugs Market Facts & Figures by Country
- 5.7.1 South America Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Radiation Injury Drugs Sales by Country (2021-2032)
- 5.7.3 South America Radiation Injury Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Radiation Injury Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Radiation Injury Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Radiation Injury Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Radiation Injury Drugs Sales by Type (2021-2032)
- 6.1.1 Global Radiation Injury Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Radiation Injury Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Radiation Injury Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Radiation Injury Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Radiation Injury Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Radiation Injury Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Radiation Injury Drugs Sales by Application (2021-2032)
- 7.1.1 Global Radiation Injury Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Radiation Injury Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Radiation Injury Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Radiation Injury Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Radiation Injury Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Radiation Injury Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Radiation Injury Drugs Value Chain Analysis
- 8.1.1 Radiation Injury Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Radiation Injury Drugs Production Mode & Process
- 8.2 Radiation Injury Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Radiation Injury Drugs Distributors
- 8.2.3 Radiation Injury Drugs Customers
9 Global Radiation Injury Drugs Analyzing Market Dynamics
- 9.1 Radiation Injury Drugs Industry Trends
- 9.2 Radiation Injury Drugs Industry Drivers
- 9.3 Radiation Injury Drugs Industry Opportunities and Challenges
- 9.4 Radiation Injury Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst